KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Short term Debt (2018 - 2025)

Cme (CME) has disclosed Short term Debt for 9 consecutive years, with $750.0 million as the latest value for Q1 2025.

  • On a quarterly basis, Short term Debt changed 0.09% to $750.0 million in Q1 2025 year-over-year; TTM through Mar 2025 was $750.0 million, a 0.09% change, with the full-year FY2024 number at $749.8 million, changed N/A from a year prior.
  • Short term Debt was $750.0 million for Q1 2025 at Cme, roughly flat from $749.8 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $750.0 million in Q1 2025 to a low of $14.5 million in Q3 2022.
  • A 5-year average of $529.4 million and a median of $749.4 million in 2021 define the central range for Short term Debt.
  • Peak YoY movement for Short term Debt: tumbled 98.06% in 2022, then soared 4496.93% in 2024.
  • Cme's Short term Debt stood at $749.4 million in 2021, then crashed by 97.86% to $16.0 million in 2022, then rose by 1.88% to $16.3 million in 2023, then skyrocketed by 4500.0% to $749.8 million in 2024, then rose by 0.03% to $750.0 million in 2025.
  • Per Business Quant, the three most recent readings for CME's Short term Debt are $750.0 million (Q1 2025), $749.8 million (Q4 2024), and $749.7 million (Q3 2024).